On July 15, China Life Insurance rose 4.68% in regular trading, trading at HKD 30.1 per share, with turnover of HKD 424 million. The stock surged following the company's interim profit forecast issued on July 14, projecting a dramatic earnings increase for the first half.

According to the filing, China Life expects attributable net profit of approximately RMB 128.9 billion to RMB 137.1 billion for H1, representing a year-over-year increase of roughly 215% to 235% compared to RMB 40.9 billion in the prior-year period. The company attributed the performance to deepened asset-liability coordination, optimized asset allocation, and enhanced professional investment capabilities delivering strong returns.

Dongwu Securities issued a Buy rating on the stock, noting profit more than tripled year-over-year. Citibank had previously anticipated profit alerts from life insurers due to significantly improved investment returns in Q2, placing China Life on its 30-day positive catalyst watchlist with a target price of HKD 36. Over the past 90 days, 17 institutions have rated the stock, with 15 issuing Buy ratings. Within the Life and Health Insurance sector, peers also gained, with AIA up 2.97%, China Taiping up 2.64%, and NCI up 1.72%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)